![](https://endpts.com/wp-content/uploads/2024/01/Maria-Grazia-Roncarolo-Stanford-Tr1x-tile1.jpg)
Maria Grazia Roncarolo, Tr1x founder
Graphite Bio co-founder debuts Treg cell therapy startup with $75M, aims to ‘trick’ immune system into resetting
Tr1x launched from stealth Wednesday with $75 million to tackle graft-versus-host disease in addition to inflammatory and autoimmune conditions.
The biotech was created by Maria …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.